OBIZUR subst sèche 500 U c solv flac 5 pce
7680658740058
CH-65874
B02BD14
1 / 3
google
Details
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Articles (1)
Obizur 500 E, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Pulver
500
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
susoctocogum alfa
|
500.0 U | Substance | Wirkstoff (Principe actif) |
|
aqua ad iniectabile
|
1.0 ML | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
calcii chloridum dihydricum
|
- | Substance | HNIDK |
|
saccharum
|
- | Substance | HNIDK |
|
trometamolum
|
- | Substance | HNIDK |
|
trometamoli hydrochloridum
|
- | Substance | HNIDK |
|
trinatrii citras dihydricus
|
- | Substance | HNIDK |
|
natrium
|
4.6 MG | Substance | HBESI |
Authorization holder
Takeda Pharma AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 65874
- Drug name
- Obizur, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
- Galenic form
- PULMJ
- ATC Code
- B02BD14
- Authorization status
- Revoked/Withdrawn
- Dispensation category
- B
- First authorization
- 23/06/2016
- Authorization expiration date
- 09/07/2025
- IT number
- 06.01.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- OBIZUR subst sèche 500 U c solv flac 5 pce
- Description (DE)
- OBIZUR Trockensub 500 E c Solv Durchstf 5 Stk
- Market launch
- 23/06/2016
- Market withdrawal
- 09/07/2025
- Narcotic (BTM)
- No